in Newswire June 10, 2020

Class Action Claims Anthem Wrongfully Denied Coverage for FDA-Approved, Pain-Treating Electrical Nerve Stimulation Device

Fortier v. Anthem, Inc. et al.

Filed: June 4, 2020 § 2:20-cv-04952

A class action alleges Anthem UM has wrongfully denied insurance coverage for an FDA-approved, clinically proven percutaneous neuromodulation therapy device.





Last Updated on June 10, 2020 — 4:59 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.